Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 6/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337083 | 0.94 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL14706992 | 0.94 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL3842117 | 0.94 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL995558 | 0.94 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL991738 | 0.87 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL2679142 | 0.87 | GPR35 (0.43) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL3371736 | 0.85 | GPR35 (0.41) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL14882940 | 0.81 | GPR35 (0.40) | GPR35SRCALOX5PTGS2KDM4E | |
| SCHEMBL23812254 | 0.79 | ACE2 (0.35) | GPR35 | |
| SCHEMBL16323051 | 0.79 | LMNA (0.33) | GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160152639-A1 | POLYMERIC COMPOUND AND ELECTRONIC ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152639-A1 | POLYMERIC COMPOUND AND ELECTRONIC ELEMENT | ARPC2, AXIN2, EMC2 | GPR35 2791/4885SRC 1080/4885ALOX5 2415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.